Phase I study of ZD9331 on short daily intravenous bolus infusion for 5 days every 3 weeks with fixed dosing recommendations.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 11230494)

Published in J Clin Oncol on March 01, 2001

Authors

B C Goh1, M J Ratain, D Bertucci, R Smith, S Mani, N J Vogelzang, R L Schilsky, M Hutchison, M Smith, S Averbuch, E Douglass

Author Affiliations

1: Section of Hematology/Oncology, Cancer Research Center, University of Chicago, Chicago, IL, USA.

Articles by these authors

(truncated to the top 100)

Nucleotide sequence of bacteriophage phi X174 DNA. Nature (1977) 95.69

Why are doctors so unhappy? There are probably many causes, some of them deep. BMJ (2001) 22.59

Evidence based medicine. BMJ (1995) 21.24

Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. Methods Enzymol (1983) 17.47

What clinical information do doctors need? BMJ (1996) 16.23

Three-dimensional structure of myosin subfragment-1: a molecular motor. Science (1993) 14.90

Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template. DNA (1984) 14.55

Informed consent: the intricacies. BMJ (1997) 13.97

Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med (2013) 13.90

The nucleotide sequence of bacteriophage phiX174. J Mol Biol (1978) 13.55

Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res (1982) 13.52

A general method for defining restriction enzyme cleavage and recognition sites. Methods Enzymol (1980) 13.26

Sequence of the gene for iso-1-cytochrome c in Saccharomyces cerevisiae. Cell (1979) 10.86

An ethical code for everybody in health care. BMJ (1998) 9.13

All changed, changed utterly. British medicine will be transformed by the Bristol case. BMJ (1998) 9.08

Growing pressure on BMJ's obituaries. BMJ (1995) 8.92

Authorship: time for a paradigm shift? BMJ (1997) 8.90

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65

The failings of NICE. BMJ (2000) 8.50

The future of medicine. BMJ (1994) 8.14

A good death. An important aim for health services and for us all. BMJ (2000) 8.03

Using evidence to inform health policy: case study. BMJ (2001) 7.99

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet (1999) 7.72

Time to face up to research misconduct. BMJ (1996) 7.66

Beyond conflict of interest. Transparency is the key. BMJ (1998) 7.63

Mutagenesis at a specific position in a DNA sequence. J Biol Chem (1978) 7.56

Report of the Committee on the Genetic Constitution of Chromosomes 7, 8 and 9. Cytogenet Cell Genet (1985) 7.28

The specific non-symmetrical sequence recognized by restriction endonuclease MboII. J Mol Biol (1980) 6.36

Meeting the information needs of health workers in developing countries. BMJ (1997) 6.31

Deletion mapping of sequences essential for in vivo transcription of the iso-1-cytochrome c gene. Proc Natl Acad Sci U S A (1981) 6.26

Medicine's core values. BMJ (1994) 5.93

Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol (1995) 5.86

Revel in electronic and paper media. BMJ (2000) 5.82

The GMC on performance. BMJ (1992) 5.57

Environmental lead and children's intelligence: a systematic review of the epidemiological evidence. BMJ (1994) 5.55

Informed consent: edging forwards (and backwards) BMJ (1998) 5.52

PubMed Central: creating an Aladdin's cave of ideas. BMJ (2001) 5.49

Does Britain need an academy of medicine? BMJ (1996) 5.47

Effect of open peer review on quality of reviews and on reviewers' recommendations: a randomised trial. BMJ (1999) 5.45

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36

Rationing: the search for sunlight. BMJ (1992) 5.26

The sequence of the DNAs coding for the mating-type loci of Saccharomyces cerevisiae. Cell (1981) 5.23

A position effect in the control of transcription at yeast mating type loci. Nature (1981) 5.23

Publishing information about patients. BMJ (1995) 5.19

The future of healthcare systems. BMJ (1997) 5.14

Prejudice against doctors and students from ethnic minorities. Br Med J (Clin Res Ed) (1987) 5.12

The war on drugs. BMJ (1996) 5.11

The distal transcription signals of the herpesvirus tk gene share a common hexanucleotide control sequence. Cell (1984) 5.10

The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend (1997) 5.10

Global information flow. BMJ (2000) 5.09

A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06

What makes a good reviewer and a good review for a general medical journal? JAMA (1998) 5.01

Four mating-type genes control sexual differentiation in the fission yeast. EMBO J (1988) 5.00

Site-specific mutagenesis using synthetic oligodeoxyribonucleotide primers: II. In vitro selection of mutant DNA. Gene (1979) 4.99

Site-specific mutagenesis using oligodeoxyribonucleotides: isolation of a phenotypically silent phi X174 mutant, with a specific nucleotide deletion, at very high efficiency. Gene (1980) 4.94

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer (2006) 4.93

Where is the wisdom...? BMJ (1991) 4.85

Medicine and the marginalised. They deserve the best, not the poorest, care. BMJ (2000) 4.80

The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75

Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature (2000) 4.68

Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron (1999) 4.68

Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67

X-ray structures of the myosin motor domain of Dictyostelium discoideum complexed with MgADP.BeFx and MgADP.AlF4-. Biochemistry (1995) 4.64

Time to register randomised trials. The case is now unanswerable. BMJ (1999) 4.55

PFI: perfidious financial idiocy. A "free lunch" that could destroy the NHS. BMJ (1999) 4.54

Moving beyond journals: the future arrives with a crash. BMJ (1999) 4.49

Rationing: the debate we have to have. BMJ (1995) 4.47

Time to redefine authorship. BMJ (1996) 4.39

Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37

Animal research: the need for a middle ground. BMJ (2001) 4.34

HIV-1 protease inhibitors. A review for clinicians. JAMA (1997) 4.34

Conflict of interest and the BMJ. BMJ (1994) 4.34

Prison medicine: beginning again. BMJ (1992) 4.29

Work system design for patient safety: the SEIPS model. Qual Saf Health Care (2006) 4.21

How biomedical investigators use library books. Bull Med Libr Assoc (1966) 4.20

Measuring the social impact of research. BMJ (2001) 4.17

The case for structuring the discussion of scientific papers. BMJ (1999) 4.16

Peer review: reform or revolution? BMJ (1997) 4.13

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. J Clin Oncol (1999) 4.12

Profile of the GMC: The day of judgment comes closer. BMJ (1989) 4.10

Managing the clinical performance of doctors. A coherent response to an intractable problem. BMJ (1999) 4.08

Effect of blinding and unmasking on the quality of peer review: a randomized trial. JAMA (1998) 4.03

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol (2001) 3.92

Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell (1983) 3.89

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83

Report of the committee on the genetic constitution of chromosomes 9 and 10. Cytogenet Cell Genet (1989) 3.79

Protein kinase activity associated with polyoma virus middle T antigen in vitro. Cell (1979) 3.78

Randomised controlled trial of general practitioner versus usual medical care in an urban accident and emergency department: process, outcome, and comparative cost. BMJ (1996) 3.76

Profile of the GMC. 1978 and all that. BMJ (1989) 3.76

"Taken from this place and hanged by the neck...". BMJ (1991) 3.72

The rights of patients in research. BMJ (1995) 3.68

All doctors are problem doctors. BMJ (1997) 3.67

The BMJ's website scales up. BMJ (1998) 3.67

Publishing research supported by the tobacco industry. BMJ (1996) 3.65

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65

How best to organise acute hospital services? BMJ (2001) 3.63

Isolation and sequence of the gene for iso-2-cytochrome c in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1980) 3.62

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62

Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell (1984) 3.61